COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 174 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,672,498 | -14.9% | 880,198 | -18.2% | 0.01% | -7.1% |
| Q2 2023 | $23,128,121 | -24.6% | 1,076,230 | -15.8% | 0.01% | -30.0% |
| Q1 2023 | $30,667,358 | -10.8% | 1,278,354 | -13.7% | 0.02% | -20.0% |
| Q4 2022 | $34,363,082 | +11.8% | 1,481,170 | -61.3% | 0.02% | +8.7% |
| Q3 2022 | $30,724,694 | -21.5% | 3,831,996 | +73.5% | 0.02% | -14.8% |
| Q2 2022 | $39,144,000 | -18.4% | 2,209,003 | -6.3% | 0.03% | +17.4% |
| Q1 2022 | $47,983,000 | -31.9% | 2,356,782 | -37.6% | 0.02% | -20.7% |
| Q4 2021 | $70,504,000 | -12.9% | 3,774,303 | -7.9% | 0.03% | -17.1% |
| Q3 2021 | $80,913,000 | -16.4% | 4,098,911 | +0.2% | 0.04% | -14.6% |
| Q2 2021 | $96,731,000 | +0.1% | 4,091,851 | +0.4% | 0.04% | -6.8% |
| Q1 2021 | $96,617,000 | -5.2% | 4,076,677 | -19.9% | 0.04% | -6.4% |
| Q4 2020 | $101,903,000 | -4.4% | 5,087,509 | -0.7% | 0.05% | -16.1% |
| Q3 2020 | $106,647,000 | +18.6% | 5,122,359 | -0.3% | 0.06% | +12.0% |
| Q2 2020 | $89,888,000 | +7.8% | 5,136,485 | +0.6% | 0.05% | -12.3% |
| Q1 2020 | $83,347,000 | -10.0% | 5,103,966 | +13.4% | 0.06% | +21.3% |
| Q4 2019 | $92,658,000 | +88.1% | 4,502,349 | +4.9% | 0.05% | +74.1% |
| Q3 2019 | $49,266,000 | -13.3% | 4,291,506 | -0.7% | 0.03% | -12.9% |
| Q2 2019 | $56,855,000 | +3.5% | 4,323,555 | +19.1% | 0.03% | +3.3% |
| Q1 2019 | $54,954,000 | -22.9% | 3,629,743 | -12.6% | 0.03% | -33.3% |
| Q4 2018 | $71,285,000 | +17.4% | 4,151,719 | +0.8% | 0.04% | +40.6% |
| Q3 2018 | $60,726,000 | -33.2% | 4,119,823 | +8.1% | 0.03% | -38.5% |
| Q2 2018 | $90,877,000 | -7.1% | 3,810,346 | -0.4% | 0.05% | -10.3% |
| Q1 2018 | $97,787,000 | +60.9% | 3,827,272 | +16.3% | 0.06% | +56.8% |
| Q4 2017 | $60,771,000 | – | 3,292,058 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 1,926,283 | $40,105,000 | 3.74% |
| Camber Capital Management LP | 4,000,000 | $83,280,000 | 2.20% |
| FRAZIER MANAGEMENT LLC | 943,666 | $19,647,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 593,741 | $12,362,000 | 1.56% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 303,685 | $6,323,000 | 1.07% |
| Eventide Asset Management | 2,427,976 | $50,550,000 | 0.99% |
| Avidity Partners Management LP | 1,000,400 | $20,828,000 | 0.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,108,219 | $23,073,000 | 0.93% |
| Perceptive Advisors | 2,058,068 | $42,849,000 | 0.63% |
| Rock Springs Capital Management LP | 1,175,000 | $24,464,000 | 0.62% |